News and commentary from the endocrinology world
— News and commentary from the endocrinology world
July 14, 2026
• 2 min read
GLP-1 drugs did not appear to improve diabetes patients' job or marriage prospects, according to a working paper from the National Bureau of Economic Research. (Axios)
The U.S. by 2035 will have 57 million overweight individuals and 94 million people with obesity, GlobalData projected.
News and commentary from the endocrinology world
News and commentary from the endocrinology world
Approved 20 years ago as a diabetes treatment, GLP-1 drugs have been found to help patients reduce weight, changing the lives of…
Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34%…
Data suggests broader use could reduce household spending on food and alcohol
Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in patients…
